Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis

30 Dec 2005

Abstract excerpt

The loss of TSC2 function is associated with the pathobiology of lymphangioleiomyomatosis (LAM), which is characterized by the abnormal proliferation, migration, and differentiation of smooth muscle-like cells within the lungs. Although the etiology of LAM remains unknown, clinical and genetic evidence provides support for the neoplastic nature of LAM. The goal of this study was to determine the role of tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Renal and related cancers
Share to Tuberous Sclerosis Complex Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16388022
DOI: 10.1165/rcmb.2005-0374oc

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in LymphangioleiomyomatosisPMID 16388022Read ↗

Lymphangioleiomyomatosis: Current understanding and potential treatments.Semantic proximity Read ↗

Clinical and molecular insights into lymphangioleiomyomatosis.Semantic proximity Read ↗

Identification of the lymphangioleiomyomatosis cell and its uterine originSemantic proximity Read ↗

Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.Semantic proximity Read ↗

[Current understanding and perspectives of lymphangioleiomyomatosis].Semantic proximity Read ↗

The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.Semantic proximity Read ↗

Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.Semantic proximity Read ↗

The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and LymphangioleiomyomatosisSemantic proximity Read ↗

STAT1 Promotes PD-L1 Activation and Tumor Growth in LymphangioleiomyomatosisSemantic proximity Read ↗

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.Semantic proximity Read ↗

Pulmonary lymphangioleiomyomatosis.Semantic proximity Read ↗

Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.